Sarepta Therapeutics SG&A Expense (TTM) Insights

Sarepta Therapeutics Inc (SRPT)

154.20 -2.55 (-1.63%) USD | NASDAQ | Jul 02, 16:00

154.01 -0.19 (-0.12%) After-Hours: 06:12

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1997. Upgrade now.

Date	Value
March 31, 2024	498.16M
December 31, 2023	481.87M
September 30, 2023	470.65M
June 30, 2023	454.54M
March 31, 2023	490.30M
December 31, 2022	451.42M
September 30, 2022	409.00M
June 30, 2022	365.34M
March 31, 2022	283.37M
December 31, 2021	282.66M
September 30, 2021	290.65M
June 30, 2021	304.90M
March 31, 2021	306.24M
December 31, 2020	317.88M
September 30, 2020	313.25M
June 30, 2020	313.31M
March 31, 2020	307.01M
December 31, 2019	284.81M
September 30, 2019	265.39M
June 30, 2019	243.00M
March 31, 2019	224.99M
December 31, 2018	207.76M
September 30, 2018	180.57M
June 30, 2018	155.70M
March 31, 2018	139.98M

Date	Value
December 31, 2017	122.85M
September 30, 2017	109.07M
June 30, 2017	103.08M
March 31, 2017	87.06M
December 31, 2016	81.72M
September 30, 2016	85.03M
June 30, 2016	77.93M
March 31, 2016	73.22M
December 31, 2015	75.04M
September 30, 2015	64.63M
June 30, 2015	62.42M
March 31, 2015	61.71M
December 31, 2014	49.32M
September 30, 2014	45.80M
June 30, 2014	40.93M
March 31, 2014	35.77M
December 31, 2013	31.59M
September 30, 2013	26.06M
June 30, 2013	21.62M
March 31, 2013	17.48M
December 31, 2012	14.63M
September 30, 2012	13.64M
June 30, 2012	13.26M
March 31, 2012	14.31M
December 31, 2011	16.06M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

265.39M

Minimum

Sep 2019

498.16M

Maximum

Mar 2024

362.67M

Average

313.31M

Median

Jun 2020

SG&A Expense (TTM) Benchmarks